Ropivacaine extended release (PainReform)

N/A

Report date: 2023/10/23 20:07:51
NME

Base Information

Drug NameRopivacaine extended release (PainReform)
Drug Alias NamePRF-110 (oily solution)PRF-110
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPain, PostoperativeBunion
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPainreform Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPainreform Ltd
Inactive CompaniesN/A
Active IndicationsBunion
Inactive IndicationsPain, Postoperative

Other Information

ATC CodeN/A
Related LinksN/A